Ikuya Usami

574 total citations
52 papers, 380 citations indexed

About

Ikuya Usami is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ikuya Usami has authored 52 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Hematology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ikuya Usami's work include Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Ikuya Usami is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Ikuya Usami collaborates with scholars based in Japan and United States. Ikuya Usami's co-authors include Masaru Kubota, Kenichiro Watanabe, Yuichi Akiyama, Ying Wei Lin, Ying‐Wei Lin, Machiko Sawada, Masaru Kubota, Seiji Koishi, Kenshi Furusho and Yoshihiro Wakazono and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Ikuya Usami

49 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikuya Usami Japan 12 137 91 86 69 65 52 380
Lidija Dokmanović Serbia 13 145 1.1× 163 1.8× 114 1.3× 109 1.6× 88 1.4× 47 419
Malin Lindqvist Sweden 8 100 0.7× 181 2.0× 102 1.2× 80 1.2× 57 0.9× 9 424
Gürses Şahin Türkiye 12 87 0.6× 74 0.8× 49 0.6× 51 0.7× 69 1.1× 45 372
Reo Tanoshima Japan 13 85 0.6× 125 1.4× 97 1.1× 136 2.0× 65 1.0× 40 456
Shoichi Koizumi Japan 9 157 1.1× 98 1.1× 98 1.1× 71 1.0× 151 2.3× 14 444
Kentaro Tsunamoto Japan 10 139 1.0× 54 0.6× 106 1.2× 46 0.7× 62 1.0× 26 514
Marianne Rodrigues Fernandes Brazil 12 149 1.1× 69 0.8× 26 0.3× 54 0.8× 100 1.5× 63 391
Sabine Plasschaert Netherlands 9 181 1.3× 124 1.4× 52 0.6× 116 1.7× 207 3.2× 25 431
J A Kohler United Kingdom 9 98 0.7× 53 0.6× 39 0.5× 45 0.7× 29 0.4× 16 316
A. Covelli Italy 11 158 1.2× 59 0.6× 134 1.6× 67 1.0× 174 2.7× 23 447

Countries citing papers authored by Ikuya Usami

Since Specialization
Citations

This map shows the geographic impact of Ikuya Usami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuya Usami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuya Usami more than expected).

Fields of papers citing papers by Ikuya Usami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuya Usami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuya Usami. The network helps show where Ikuya Usami may publish in the future.

Co-authorship network of co-authors of Ikuya Usami

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuya Usami. A scholar is included among the top collaborators of Ikuya Usami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuya Usami. Ikuya Usami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goto, Hironori, Souichi Suenobu, Yuhki Koga, et al.. (2025). H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study. SHILAP Revista de lepidopterología. 4.
4.
Hori, Hiroki, Tooru Kudoh, Shin‐Ichiro Nishimura, et al.. (2016). Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. International Journal of Clinical Oncology. 22(2). 387–396. 10 indexed citations
5.
Yoshioka, Akira, Ikuya Usami, Masao Kobayashi, et al.. (2015). The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors. International Journal of Hematology. 101(4). 362–368. 3 indexed citations
6.
Nagai, Ayako, Masaru Kubota, Li Yoong Tang, et al.. (2011). Hyperuricemia in Pediatric Malignancies Before Treatment. Nucleosides Nucleotides & Nucleic Acids. 30(12). 1060–1065. 5 indexed citations
7.
Nagai, Ayako, Masaru Kubota, Souichi Adachi, et al.. (2011). Fatigue in survivors of childhood acute lymphoblastic and myeloid leukemia in Japan. Pediatrics International. 54(2). 272–276. 13 indexed citations
8.
Kubota, Masaru, Souichi Adachi, Ikuya Usami, et al.. (2010). Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study. International Journal of Hematology. 91(2). 252–257. 21 indexed citations
9.
Kubota, Masaru, et al.. (2008). Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. Journal of Paediatrics and Child Health. 44(6). 359–362. 22 indexed citations
10.
Kobayashi, Kenichiro, Ikuya Usami, Masaru Kubota, Toshikazu Nishio, & Naoki Kakazu. (2005). Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome. Cancer Genetics and Cytogenetics. 158(2). 184–187. 8 indexed citations
11.
Katamura, Kenji, Shin Okazaki, Ikuya Usami, Tadao Tsuboyama, & Nobuaki Takeda. (2001). Multifocal osteomyelitis and erythematous plaque associated with Yersinia pseudotuberculosis infection. Pediatrics International. 43(6). 711–713. 2 indexed citations
12.
Kubota, Masaru, et al.. (2000). On the role of mitochondrial complex I in apoptosis induced by anti-cancer drugs. 41. 823. 1 indexed citations
13.
Lin, Ying‐Wei, Masaru Kubota, Seiji Koishi, et al.. (1998). Analysis of mutations at the DNA repair genes in acute childhood leukaemia. British Journal of Haematology. 103(2). 462–466. 6 indexed citations
14.
Sawada, Machiko, Masaru Kubota, Ying‐Wei Lin, et al.. (1998). Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 397(2). 337–343. 16 indexed citations
15.
Kubota, Masaru, Machiko Sawada, Kenichiro Watanabe, et al.. (1997). Myelodysplastic syndrome presenting as third malignancy after non-Hodgkin's lymphoma and osteosarcoma. Annals of Hematology. 74(2). 95–97. 2 indexed citations
16.
Lin, Ying‐Wei, Masaru Kubota, Yoshihiro Wakazono, et al.. (1996). Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy. Mutation Research/DNA Repair. 362(1). 97–103. 11 indexed citations
17.
Kubota, Masaru, Machiko Sawada, Seiji Koishi, et al.. (1996). Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor. Journal of Cellular Physiology. 168(1). 183–187. 8 indexed citations
19.
Kubota, Masaru, Yoshihiro Wakazono, Ying Wei Lin, et al.. (1995). Association of high molecular weight DNA fragmentation with apoptotic or non‐apoptotic cell death induced by calcium ionophore. FEBS Letters. 364(3). 264–267. 33 indexed citations
20.
Kubota, Masaru, et al.. (1995). Selection and Partial Characterization of Calcium Ionophore (A23187) Resistant Cells. Biochemical and Biophysical Research Communications. 213(2). 541–549. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026